Literature DB >> 2445832

Virus interference. I. The interferon. By A. Isaacs and J. Lindenmann, 1957.

A Isaacs, J Lindenmann.   

Abstract

Mesh：

Substances：

Year:  1987        PMID： 2445832     DOI： 10.1089/jir.1987.7.429

Source DB:  PubMed          Journal:  J Interferon Res        ISSN： 0197-8357


× No keyword cloud information.
  34 in total

Review 1.  Type III Interferons in Antiviral Defenses at Barrier Surfaces.

Authors:  Alexandra I Wells; Carolyn B Coyne
Journal:  Trends Immunol       Date:  2018-09-12       Impact factor: 16.687

2.  The tetracycline-responsive promoter contains functional interferon-inducible response elements.

Authors:  A Rang; H Will
Journal:  Nucleic Acids Res       Date:  2000-03-01       Impact factor: 16.971

3.  Sphingosine 1-Phosphate Lyase Enhances the Activation of IKKε To Promote Type I IFN-Mediated Innate Immune Responses to Influenza A Virus Infection.

Authors:  Madhuvanthi Vijayan; Chuan Xia; Yul Eum Song; Hanh Ngo; Caleb J Studstill; Kelly Drews; Todd E Fox; Marc C Johnson; John Hiscott; Mark Kester; Stephen Alexander; Bumsuk Hahm
Journal:  J Immunol       Date:  2017-06-09       Impact factor: 5.422

4.  Molecular and functional analysis of an interferon gene from the zebrafish, Danio rerio.

Authors:  Stephen M Altmann; Mark T Mellon; Daniel L Distel; Carol H Kim
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

Review 5.  Discovering antiviral restriction factors and pathways using genetic screens.

Authors:  Chloe E Jones; Wenfang S Tan; Finn Grey; David J Hughes
Journal:  J Gen Virol       Date:  2021-05       Impact factor: 3.891

6.  Evaluating viral interference between Influenza virus and Newcastle disease virus using real-time reverse transcription-polymerase chain reaction in chicken eggs.

Authors:  Shengqiang Ge; Dongxia Zheng; Yunling Zhao; Hualei Liu; Wenbo Liu; Qing Sun; Jinming Li; Songmei Yu; Yuanyuan Zuo; Xiuju Han; Lin Li; Yan Lv; Yingli Wang; Xiufan Liu; Zhiliang Wang
Journal:  Virol J       Date:  2012-07-01       Impact factor: 4.099

Review 7.  Dermatomyositis after interferon alpha treatment.

Authors:  L L Dietrich; A J Bridges; M R Albertini
Journal:  Med Oncol       Date:  2000-02       Impact factor: 3.738

8.  Sensitivity of FCV to recombinant feline interferon (rFeIFN).

Authors:  Kyoko Ohe; Toshikazu Takahashi; Daisuke Hara; Motonobu Hara
Journal:  Vet Res Commun       Date:  2007-10-02       Impact factor: 2.816

9.  Production of IFN-β during Listeria monocytogenes infection is restricted to monocyte/macrophage lineage.

Authors:  Evgenia Solodova; Jadwiga Jablonska; Siegfried Weiss; Stefan Lienenklaus
Journal:  PLoS One       Date:  2011-04-11       Impact factor: 3.240

Review 10.  Blocking type I interferon production: a new therapeutic option to reduce the HIV-1-induced immune activation.

Authors:  Moritz Ries; Kathrin Pritschet; Barbara Schmidt
Journal:  Clin Dev Immunol       Date:  2011-11-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.